|
Volume 272, Number 7,
Issue of February 14, 1997
pp. 4121-4128
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
UDP-galactofuranose Precursor Required for Formation of the
Lipopolysaccharide O Antigen of Klebsiella pneumoniae
Serotype O1 Is Synthesized by the Product of the
rfbDKPO1 Gene*
(Received for publication, September 16, 1996, and in revised form, November 11, 1996)
Reinhard
Köplin
,
Jean-Robert
Brisson
§ and
Chris
Whitfield
¶
From the Canadian Bacterial Diseases Network,
Department of Microbiology, University of Guelph,
Guelph, Ontario, Canada, N1G 2W1, and the § Institute
for Biological Sciences, National Research Council, Ottawa,
Ontario, Canada, K1A 0R6
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
Note Added in Proof
REFERENCES
ABSTRACT
The O-side-chain polysaccharide in the
lipopolysaccharide of Klebsiella pneumoniae O1 is based on
a backbone structure of repeat units of
[ 3)- -D-Galf-(1 3)- -D-Galp-(1 ];
this structure is termed D-galactan I. The rfb
(O-antigen biosynthesis) gene cluster directs the synthesis of
D-galactan I and consists of six genes termed
rfbA-FKPO1. In this paper we show that
rfbDKPO1 encodes a UDP-galactopyranose mutase
(NAD(P)H-requiring) (EC 5.4.99.9), which forms uridine 5 -(trihydrogen
diphosphate) P - -D-galactofuranosyl ester
(UDP-Galf), the biosynthetic precursor of galactofuranosyl residues. The deduced amino acid sequence of
rfbDKPO1 shows 85% and 37.5% identity to the
rfbDKPO8 gene of K. pneumoniae
serotype O8 and the glf gene of Escherichia
coli, respectively. The molecular mass of the purified
RfbDKPO1 enzyme is 45 kDa as determined by SDS-polyacrylamide gel electrophoresis, while gel filtration revealed a
molecular mass of 92 kDa, suggesting a dimeric structure for the native
protein. The rfbDKPO1 gene product
interconverts uridine 5 -(trihydrogen diphosphate)
P - -D-galactopyranosyl ester (UDP-Galp) and
UDP-Galf. Unlike Glf, RfbDKPO1 showed a
requirement for NADH or NADPH, which could not be replaced by NAD or
NADP. RfbDKPO1 was used to synthesize milligram quantities
of UDP-Galf, allowing this compound to be purified and
fully characterized in an intact form for the first time. The structure
of UDP-Galf was proven by NMR spectroscopy.
INTRODUCTION
Lipopolysaccharide (LPS)1 is a major
component of the outer membrane of Gram-negative bacteria. In enteric
bacteria, the LPS molecule comprises a hydrophobic lipid A portion,
which forms the outer leaflet of the outer membrane, a core
oligosaccharide, and an O-side-chain polysaccharide. The O
polysaccharide varies in structure from strain to strain, giving rise
to unique antigenic epitopes (O antigens). In the genus
Klebsiella, there exists a family of structurally related
galactose-containing O polysaccharides. These are based on a backbone
structure consisting of a disaccharide O-repeat unit
[ 3)- -D-Galf-(1 3)- -D-Galp-(1 ]
known as D-galactan I (1). Variations in O antigens arise
from addition of side-chain -D-Galp (2) and
O-acetyl (2, 3) residues, or by addition of domains of
varying structure (1, 4-6). Galactofuranosyl residues are present in a
growing number of LPS O antigens e.g. in strains of
Serratia marcescens (7, 8), Shigella dysinteriae (9), Shigella boydii (10), Escherichia coli (11),
Pasteurella hemolytica (12), Hemophilus
pleuropneumoniae (13), and Actinobacillus pleuropneumoniae (14). The T1-antigen polysaccharide of
Salmonella friedenau (15) and a variety of capsular or
extracellular polysaccharides from both Gram-negative and Gram-positive
bacteria (e.g. Refs. 16-20) contain Galf.
Galactofuranosyl residues are a central component in the
mycolyl-arabinogalactan complex, which is characteristic of the cell
walls of mycobacteria (21) and the related genera Nocardia
and Rhodococcus (22), in the lipoglycan of Mycoplasma mycoides (23), in the paracrystalline S-layer glycoprotein of Clostridium thermohydrosulfuricum S102-70 (24), and in the
cellulosome glycoproteins of Clostridium thermocellum (25)
and Bacteroides cellulosolvens (26). In eukaryotes,
galactofuranosyl residues are found in the lipophosphoglycan of
Leishmania donovani (27), Leishmania major (28),
and Leishmania mexicana (29), in the N-linked
glycoproteins of Crithidia spp. (30), and in the
lipopeptidophosphoglycan of Trypanosoma cruzi (31). A
variety of fungal cell surface glycans, glycolipids and glycoproteins
contain Galf residues in Penicillium spp.
(32-34), Aspergillus spp. (35), Neurospora
crassa (36), and Histoplasma capsulatum (37). Many of
these microorganisms are important pathogens, and, for some, current
therapies are limited. This observation, together with the absence of
Galf residues in human glycoconjugates has fueled interest
in the potential of generating novel therapeutic compounds directed
against reactions involved in the formation of Galf
precursors (38).
In the prototype system in K. pneumoniae O1,
D-galactan I biosynthesis is directed by enzymes encoded by
six genes in the chromosomal rfb locus. The polymer is
synthesized in the cytoplasm by RfbCDEF activities and is then
transported across the plasma membrane by a process involving an
ATP-binding cassette (ABC-2) transporter, where RfbA is the
transmembrane component and RfbB contains the consensus ATP-binding
motifs (39). The synthesis of D-galactan I is initiated on
a "primer" comprising undecaprenyl pyrophosphoryl
N-acetylglucosamine. The primer is formed by the activity of
the Rfe protein which appears to be an UDP-GlcNAc:undecaprenylphosphate GlcNAc-1-phosphate transferase (40). RfbF is a bifunctional galactosyl
transferase, which forms the disaccharide
[ 3)- -D-Galf-(1 3)- -D-Galp-1( ] on the primer (41). The details of the subsequent polymerization reaction(s) have not yet been resolved.
The precursor for Galp residues is UDP-Galp (42),
formed by the action of UDP-galactose 4-epimerase, encoded by the
galE gene in the galactose operon (43). Early studies on the
biosynthesis of the T1 antigen in S. enterica serovar
Typhimurium (44, 45) suggested that Galf precursors were
derived from Galp at the level of UDP-linked sugars. The
Galf precursor for a galactofuranosyl-containing polysaccharide in Penicillium charlesii was also proposed to
be a UDP-linked derivative (46). More recently, the product of orf6, an
enzyme encoded by the cryptic rfb locus in E. coli K-12 strains (47), was shown to have UDP-galactopyranose
mutase (EC 5.4.99.9) activity, capable of the reversible formation of
UDP-Galf from UDP-Galp (48). The product
UDP-Galf was predicted from degradation products and this
compound has not been isolated and fully characterized in an intact
state.
This paper reports the cloning, expression, and purification of
RfbDKPO1 from K. pneumoniae O1. We show that the
enzyme has UDP-galactopyranose mutase activity but differs in several
important aspects from the homologue from E. coli K-12. In
addition, we report the isolation and first complete chemical
characterization of intact UDP-Galf.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions
The
strains and plasmids used in this study are given in Table
I. Strains were grown in Luria-Bertani (LB) medium
containing the appropriate antibiotics. Antibiotics were used at the
following concentrations: ampicillin, 100 µg/ml; kanamycin, 50 µg/ml; chloramphenicol, 50 µg/ml.
DNA Manipulation and Analysis
Restriction endonuclease
digestion, ligation, and transformation were performed essentially as
described by Sambrook et al. (49). Plasmid DNA preparations
were made with QIAGEN Inc. columns according to the manufacturer's
instructions. CLUSTAL W was used for the multiple alignment (50) using
default parameters.
Plasmid Construction
pWQ71 was constructed by cloning a
XbaI-HindIII fragment of pWQ5 containing the
complete rfbKPO1 gene cluster into pBBR1MCS. In
order to delete an internal region in rfbDKPO1,
plasmid pWQ5 was mutagenized using a Transformer site-directed
mutagenesis kit (Clontech), which is based on the method of Deng and
Nickoloff (51). The 5 -phosphorylated primers 5 -CAT GTT TAT
CAT ATT TTC C-3 and 5 -GAT TAC CAG
GCA GTG ATG-3 were used to introduce a
BamHI site (underlined) in the 5 and 3 -regions of
rfbDKPO1, respectively. The 5 -phosphorylated
selection primer 5 -GCC TTT TTA CTT AGT AAT CCT AAA G-3 alters a
unique CelII site in rfbFKPO1 and was
used as selection primer. Digestion of this construct with
BamHI, followed by religation, resulted in an in-frame
deletion of 630 base pairs. The rfbKPO1 gene
cluster containing the rfbDKPO1 deletion was
subsequently cloned into pBBR1MCS on a
XbaI-HindIII fragment, resulting in pWQ70. To
clone the rfbDKP01 open reading frame, plasmid
pWQ5 was mutagenized using the Transformer site-directed mutagenesis
kit (Clontech) in order to introduce NdeI and
HindIII sites overlapping with the start and stop codons of
rfbDKPO1, respectively. The
NdeI-HindIII fragment containing the entire
rfbDKPO1 open reading frame was cloned into
pET30a(+) (Novagen), resulting in pWQ66.
SDS-PAGE of LPS
LPS samples were routinely prepared by the
SDS-proteinase K lysate method (52). Samples were analyzed by SDS-PAGE
according to the conditions described by Lesse et al. (53),
and gels were silver-stained by the method of Tsai and Frasch (54).
Overexpression of RfbDKPO1
An overnight culture
of E. coli CWG288 (pWQ66) was diluted 1:200 into fresh
medium (LB, 250 mM sorbitol, 50 µg/ml kanamycin) and
grown to an A580 of 0.5. Galactose and
isopropyl-1-thio- -D-galactopyranoside were added to a
final concentration of 10 mM and 0.4 mM,
respectively. The cells were then grown for an additional 3 h at
37 °C, collected by centrifugation at 7,800 × g,
4 °C for 10 min, and stored at 70 °C in aliquots of 1 g of
wet cell paste.
Extraction of Nucleotide Sugars
For the extraction of sugar
nucleotides, 1 g of wet cell paste was resuspended in 5 ml of 75%
ethanol and incubated at 100 °C for 10 min. Cell debris was removed
by centrifugation (20,000 × g, 10 min) and reextracted
with another 5 ml of 75% ethanol. The samples were evaporated to
dryness and redissolved in a small volume of water. Insoluble material
was removed by centrifugation.
Purification of the RfbDKPO1 Protein of K. pneumoniae
Serotype O1
Wet cell paste (1 g) was resuspended in 9 ml of 50 mM HEPES, pH 7.0, 1 mM phenylmethylsulfonyl
fluoride, 0.1 mM dithiothreitol, and the suspension was
disrupted by sonication. Cell debris was removed by centrifugation at
20,000 × g for 30 min, followed by ultracentrifugation
at 100,000 × g for 1 h. The 100,000 × g supernatant was further fractionated by ammonium sulfate
precipitation at 4 °C. The fraction between 55% and 75% saturation
contained the RfbDKPO1 protein and was dialyzed against 50 mM HEPES pH 7.0 overnight, and then concentrated to ~ 0.5 ml using a ultrafiltration cartridge (Centriplus 30, Amicon).
RfbD was further purified by dye-ligand affinity chromatography on 5-ml
columns of Reactive Green 5-agarose (Sigma) and Cibacron Blue
3GA-agarose (Sigma) at room temperature. The concentrated protein
fraction was applied to the Reactive Green 5-column preequilibrated
with 50 mM HEPES pH 7.0 and washed with 25 ml of 50 mM HEPES pH 7.0. This column bound the majority of applied
protein, while most of the RfbDKPO1 protein was not retained under this conditions. The unbound fraction was subsequently applied to a 5-ml column of Cibacron Blue 3GA-agarose equilibrated with
50 mM HEPES pH 7.0, washed with 25 ml of 50 mM
HEPES pH 7.0. The rfbDKP01 protein was eluted
with 10 ml of 1 mM UDP-Galp in 50 mM
HEPES pH 7.0. Residual contaminating proteins were removed by anion
exchange chromatography on MonoQ at room temperature, using a linear
sodium chloride gradient (0-300 mM) in 50 mM
HEPES pH 7.0.
Enzyme Reactions
UDP-galactopyranose mutase reactions were
performed at 37 °C for 30 min. The reaction mixture consisted in a
total volume of 100 µl: 50 mM HEPES pH 7.0, 1 mM UDP-Galp (UDP-Galf), 2 mM NADH or NADPH, and variable amounts of
UDP-galactopyranose mutase (NAD(P)H-requiring). The reaction products
were analyzed by HPAEC on CarboPac PA1 (Dionex).
HPLC Analysis
Sugar nucleotides were analyzed on a CarboPac
PA1 column (4 × 250 mm) according to the method of Palmieri
et al. (55) with minor modifications. Sugar nucleotides were
separated using a linear ammonium acetate (pH 7.0) gradient from 200 to
500 mM in 50 min at a flow rate of 0.6 ml/min. UDP-sugars
were detected at 262 nm. For the purification of larger quantities of
UDP-Galf, a CarboPac PA1 column (9 × 250 mm) operated
at a flow rate of 3 ml/min was used. Separated compounds were recovered
by lyophilization.
NMR Analysis
The 1H, 13C, and
31P spectra were recorded on a Bruker AMX-600 spectrometer,
at 285 K using a 5-mm broadband tunable probe. The sample was prepared
from 0.5 mg of UDP-Galf in ammonium acetate buffer,
lyophilized, and redissolved in 0.6 ml of 10 mM potassium phosphate buffer (pH 7.2), containing 0.5 mM EDTA. The pH
of the sample dropped below 6; therefore, additional
K2HPO4 was immediately added to adjust the pH
to 6.8. The sample was then lyophilized and redissolved in 0.6 ml of
D2O and transferred to a 5-mm NMR tube. Acetone was added
to the sample to provide the internal proton chemical shift reference
at 2.225 ppm. The methyl resonance of an external acetone in
D2O, set at 31.07 ppm, was used for the 13C
chemical shift reference. The chemical shift reference for
31P was that of external phosphoric acid (25%) in
D2O set at 0.0 ppm. All of the experiments were carried out
without sample spinning and with the standard software and pulse
programs provided by Bruker. The J(H,H) and
J(P,H) coupling constants were measured directly
from the one-dimensional 1H or 31P spectra
processed with a digital resolution of 0.2 Hz/point.
The 1H spectrum of 256 scans was recorded with
presaturation of the HOD resonance at 4.945 ppm. The 13C
spectrum with proton decoupling was recorded overnight with 50,000 scans. The 31P spectrum of 4000 scans was recorded without
proton decoupling. The two-dimensional homonuclear magnitude COSY,
phase-sensitive TOCSY, 1H-31P HMQC,
1H-13C HMQC experiments were recorded and
processed as described previously (56). The one-dimensional TOCSY
z-filtered spectra of 2000 scans was performed as described
previously (57).
RESULTS
The K. pneumoniae Serotype O1 rfbDKPO1 Gene Encodes a
Functional Homologue of Glf of E. coli K-12
The
rfbKPO1 gene cluster that directs formation of
D-galactan I (39, 42) consists of six genes termed
rfbA-F. The rfbDKPO1 open reading
frame comprises 1152 nucleotides. No consensus ribosome binding site
was found upstream of the ATG initiation codon of rfbDKPO1. The TGA stop codon of
rfbDKPO1 overlaps with the ATG initiation codon
of rfbEKPO1, suggesting translational coupling. The predicted translational product of rfbDKPO1
is a 384-amino acid protein with a molecular weight of 44,454 and a
theoretical pI of 6.06. The N-terminal region between Lys-5 and Asp-33
contains a signature for an ADP-binding   -fold involved in FAD
or NAD binding (58). The sequence deviates only at Gly-19 from the fingerprint. Consequently, a BLAST search (59) revealed striking similarities of the N terminus of rfbDKPO1 to
flavin-containing oxidases and dehydrogenases. Across the entire
predicted polypeptide, 85% and 37.5% identity were found to the
rfbDKPO8 gene of K. pneumoniae serotype O8 (also comprising D-galactan I (3, 60) and the glf (orf6) gene of E. coli K-12, respectively
(Fig. 1).
Fig. 1.
Multiple alignment of the deduced amino-acid
sequences of rfbDKPO1,
rfbDKPO8, and glf (orf6) of
E. coli K-12. The alignment was derived using CLUSTAL
W with default parameters. Identical residues are marked by
asterisks; similar residues are marked by
periods.
[View Larger Version of this Image (75K GIF file)]
Direct evidence that rfbDKPO1 encodes a Glf
homologue was obtained from complementation experiments. The
rfbKPO1 gene cluster was cloned into pBBR1MCS
resulting in pWQ71. Site-directed mutagenesis was used to generate
plasmid pWQ70, which contains an in-frame deletion of 630 base pairs in
the rfbDKPO1 gene of the D-galactan I gene cluster. A physical map of the DNA fragments cloned into pWQ70
or pWQ71 is given in Fig. 2. The LPS phenotypes
conferred by these plasmids were analyzed by SDS-PAGE in DH5 and a
derivative of strain SØ874 (CWG287). The glf gene, located
in the cryptic E. coli K-12 rfb region (47, 61),
is deleted in E. coli SØ874. The LPS of DH5 or CWG287
both containing the complete cluster (pWQ71) showed a ladder of smooth
LPS (S-LPS) (Fig. 3). Deletion of the internal region of
rfbDKPO1 in pWQ70 resulted in no phenotypic alterations in DH5 , while in CWG287 the synthesis of S-LPS was completely abolished (Fig. 3), suggesting that a gene of the cryptic rfb cluster of E. coli K-12, most likely
glf, is functionally equivalent to rfbD
KPO1.
Fig. 2.
Structure and organization of the
rfb gene cluster from K. pneumoniae serotype
O1. A, partial restriction map of the K. pneumoniae
rfbKPO1 cluster, cloned into pBBR1MCS (pWQ71).
B, structure of the rfbKPO1 cluster
containing a 630-base pair in-frame deletion in
rfbDKPO1 (pWQ70). The location and orientation
of the rfbA-FKPO1 genes are indicated by arrows
below the restriction map. Only insert DNA is shown.
[View Larger Version of this Image (14K GIF file)]
Fig. 3.
Silver-stained SDS-PAGE gel showing the LPS
phenotype of a rfbDKPO1 deletion-derivative
(pWQ70) in E. coli DH5 and CWG287. Synthesis of
D-galactan I results in high molecular weight ladders of
S-LPS. The rfbDKP01 deficiency is complemented
by a chromosomal locus in E. coli DH5 , or by supplying
pWQ66 in trans. Plasmid pWQ66 carries a functional copy of
rfbDKP01.
[View Larger Version of this Image (52K GIF file)]
An E. coli K-12 rfb Strain Overexpressing RfbDKPO1
Accumulates UDP-Galp and a Novel Galactose-containing UDP
Derivative
The function of RfbDKPO1 was further
addressed by analyzing the UDP-sugars synthesized in vivo.
In order to achieve high level expression of RfbDKPO1, a
NdeI and a HindIII site overlapping with the
start and stop codon of rfbDKPO1, respectively,
were introduced by site-directed mutagenesis. The
NdeI-HindIII fragment containing only the
rfbDKPO1 open reading frame was cloned into the
T7 expression vector pET30a(+), resulting in pWQ66. The functionality of the rfbDKPO1 gene was proven by
complementation of CWG287 (pWQ70). When pWQ66 was transformed into
CWG287 (pWQ70), the synthesis of S-LPS was restored, even without
isopropyl-1-thio- -D-galactopyranoside induction (Fig.
3). To avoid further metabolism of in vivo synthesized UDP-Galp or UDP-Galf, CWG288 (E. coli
K-12 rfb DE3 galE) was constructed as a
galE derivative of CWG287. Additionally, sorbitol, which has
been reported to suppress elevated levels of UDP-sugar hydrolase
activity as a result of UDP-galactose accumulation (62), was added to
the medium to avoid enzymatic degradation. Nucleotide sugars were
extracted from CWG288 (pWQ66) and from the control strain CWG288
(pET30a(+)), and extracts were analyzed by HPAEC. From Fig.
4 it can be seen that both strains accumulated
UDP-Galp (retention time 34.5 min), while an additional peak
(p37) with a retention time of 37.5 min was unique to extracts of
CWG288 (pWQ66). In experiments using [1-14C]galactose,
p37 was found to contain about 5% of the radioactivity, with the
remaining 95% confined to the UDP-Galp peak (data not shown), suggesting that p37 is a novel galactose-containing sugar nucleotide formed by the activity of RfbDKPO1.
Fig. 4.
HPLC elution profile of nucleotide sugars
extracted from CWG288 (pWQ66) and CWG288 (pET30a(+)). Nucleotide
sugars were extracted with boiling ethanol, evaporated to dryness,
redissolved in water, and analyzed by HPAEC on a CarboPac PA1 using a
linear ammonium acetate gradient from 200-500 mM. Only the
relevant parts of the elution profiles are shown.
[View Larger Version of this Image (10K GIF file)]
Purification and Characterization of the RfbDKPO1
Protein
In order to unequivocally determine the function of
RfbDKPO1 and the nature of p37, the RfbDKPO1
protein was purified to homogeneity from CWG288 (pWQ66) by ammonium
sulfate precipitation, dye-ligand affinity chromatography, and anion
exchange chromatography as described in detail under "Experimental
Procedures." The protein was homogeneous as judged by SDS-PAGE (Fig.
5). The molecular mass of 45,000 Da of the denatured
polypeptide determined by SDS-PAGE is in good agreement with the
predicted molecular weight of 44,454. However, gel filtration on
Superose 12 revealed a molecular weight of 92,000, suggesting a dimeric
structure for the native protein (data not shown).
Fig. 5.
SDS-PAGE analysis of the RfbDKPO1
purification. Lane 1, 100,000 × g
supernatant; lane 2, ammonium sulfate precipitate; lane 3, RfbDKPO1 eluted from Cibacron
3FG-agarose with 1 mM UDP-Galp; lane
4, concentrated fraction from MonoQ anion-exchange chromatography. The positions of the SDS-PAGE marker proteins phosphorylase
b (97.4 kDa), serum albumin (66.2 kDa), ovalbumin (45.0 kDa), carbonic anhydrase (31.0 kDa), trypsin inhibitor (21.5 kDa), and
lysozyme (14.4 kDa) are indicated.
[View Larger Version of this Image (59K GIF file)]
An in vitro assay was used to gain more information on the
RfbDKPO1-mediated reaction. The enzyme reaction was carried
out in a total volume of 100 µl, and the reaction products obtained after incubation at 37 °C for 30 min were analyzed by HPAEC on a
CarboPac PA1. The enzyme showed an absolute requirement for NADH or
NADPH (data not shown). Under these reaction conditions, a peak well
separated from UDP-Galp or UDP-Glc with the same retention time as p37 was obtained (Fig. 6B). In all
experiments about 5% of UDP-Galp was converted to p37. No
reaction could be seen in assays lacking the cofactor, or in assays
containing NAD or NADP. When pooled p37 was used as substrate in the
enzyme assay, ~95% was converted back to UDP-Galp (Fig.
6C), while no reaction was observed in assays lacking a
cofactor or in assays with NAD or NADP (data not shown). Other than the
cofactor requirements, these data are in agreement with the data
described for Glf of E. coli (48) and further support the
conclusion that p37 indeed is UDP-Galf.
Fig. 6.
HPLC profiles of purified
UDP-Galf and the reaction products of the
UDP-galactopyranose mutase assays. A, HPLC profile of a
mixture of UMP, UDP-Galp, and UDP-Glc. B,
reaction products obtained with UDP-Galp as substrate.
C, reaction products obtained using UDP-Galf as
substrate. D, purified UDP-Galf.
[View Larger Version of this Image (10K GIF file)]
NMR Analysis of UDP-Galf
In order to unequivocally prove that
p37 is UDP-Galf, about 1.5 mg of p37 was pooled from several
HPLC runs on a semipreparative CarboPac PA1 (9 × 250 mm). After
lyophilization, a small amount was redissolved in 100 mM
ammonium acetate, pH 7.0, and analyzed by HPAEC. The material was found
to be >95% pure (Fig. 6D) as judged by peak integration.
During preparation of the sample for NMR analysis, the pH of the sample
dropped below pH 6.0, which resulted in partial degradation of the
nucleotide sugar. However, a complete assignment by two-dimensional
methods of all proton, carbon, and phosphorous NMR resonances permitted
the identification of intact p37 and of all the major components of the
sample. By integration of the 1H spectrum, the sample was
found to be a mixture of the following major components: 26%
UDP-Galf, 53% 5 -UMP, and 21% Galf-1,2-P. The
1H spectrum is shown in Fig. 7, together
with subspectra for the Galf moiety of UDP-Galf
and Galf-1,2-P. The 1H-13C HMQC is
shown in Fig. 8A along with the
1H and 13C spectra. The
1H-31P HMQC spectrum is shown in Fig.
8B, along with the 1H and 31P
spectra. Proton, 13C and 31P chemical shifts
are given in Tables
II, III, IV. Coupling constants for 31P are in Table V and
J(H,H) coupling constants in Table
VI. Due to limited quantities of material, the low
signal to noise in the 13C spectrum did not permit the
measurement of J(C,P) couplings.
Fig. 7.
Proton NMR-spectra of UDP-Galf
and Galf-1,2-P. The 1H spectrum is shown
in A. The sums of the one-dimensional TOCSY z-filtered
spectra with a mixing time of 60 ms for selective excitation of the H1
and H4 resonances of the Galf residue in UDP-Galf
(B) and for selective excitation of the H2 and H5 resonances
of the Galf-1,2-P (C) are also shown.
[View Larger Version of this Image (18K GIF file)]
Fig. 8.
NMR characterization of UDP-Galf
and Galf-1,2-P. A, the
1H-13C HMQC spectrum along with the
13C spectrum and resolution enhanced 1H
spectrum. The resonances for the Galf residue of
UDP-Galf are labeled. B, the
1H-31P HMQC spectrum along with the
31P spectrum and the resolution enhanced 1H
spectrum.
[View Larger Version of this Image (21K GIF file)]
UDP-Galf
The 31P spectrum showed the presence of
various phosphorylated compounds, one of which contained a
pyrophosphate group that has characteristic shifts at 11.2 ppm and
12.4 ppm and a J(P ,P ) coupling constant
of 21 Hz (63). A 1H-31P HMQC spectrum indicated
the proton resonances, which were coupled to the pyrophosphate group.
The proton resonances at 5.629 ppm and 4.152 ppm, which were coupled to
the 31P resonance at 12.4 ppm had
J(P,H) coupling constants of 5.5 Hz and 2.3 Hz,
respectively. The complete coupled spin system for these proton
resonances was identified by COSY, TOCSY, and one-dimensional TOCSY
experiments. The proton-proton coupling constants
(J(H,H)) could be obtained from the
one-dimensional TOCSY spectrum. A 1H-13C HMQC
permitted the assignment of all the carbon atoms directly bonded to
these protons (C-H). The proton chemical shifts,
J(H,H) coupling constants, 13C
chemical shifts (64), and 31P chemical shifts were all
characteristic of a terminal -Galf residue bonded to a
pyrophosphate group.
From a similar analysis, the resonances at 4.24 and 4.21 ppm, which
bonded to the pyrophosphate resonance at 11.2 ppm, were found to
belong the H5 and H5" resonances of the ribose moiety of
UDP-Galf. The proton chemical shifts,
J(H,H) coupling constants, and
J(P,H) coupling constants of the UDP moiety were
found to be characteristic for those found for UDP sugars (65).
5 -UMP
In the 1H-31P HMQC spectrum,
the 31P resonances at 3.5 ppm bonded to the proton
resonances at 4.032 ppm and 3.970 ppm were found to belong to 5 -UMP by
a complete assignment of the 1H and 13C
spectra. The proton chemical shifts, J(H,H)
coupling constants, and J(P,H) coupling
constants of the 5 -UMP were found to be similar to those previously
reported for this compound (66).
Galf-1,2-P
The 31P resonance at 17.1 ppm is
characteristic of a five-membered cyclic ester (63). In the
1H-31P HMQC spectrum, this 31P
resonance was coupled to the proton resonances at 6.000 ppm and 4.813 ppm, with J(P,H) coupling constants of 14 Hz and
6.8 Hz, respectively. From the assignment of the proton spin system for
this residue obtained from the COSY and one-dimensional TOCSY experiment, the H1 and H2 resonances were found to be coupled to the
cyclic phosphate.
DISCUSSION
Galactofuranosyl residues are found in a growing number of surface
glycoconjugates from both Gram-negative and Gram-positive bacteria, as
well as protozoa and fungi. These include well documented pathogens of
humans and livestock. In bacteria (this work, and Refs. 44, 45, and 48)
and fungi (46), the biosynthetic precursor for Galf residues
is believed to be UDP-Galf. Galactofuranosyl-containing glycoconjugates have not been reported in humans so far, which makes
UDP-Galf formation an interesting target for novel
therapeutic compounds (38). However, development of strategies for
inhibitors has been limited by the lack of fundamental information
regarding the biosynthesis of galactofuranosyl residues.
Galactocarolose, a -D-(1 5)-linked
polygalactofuranosid produced by P. charlesii, was the first
polysaccharide found to contain galactofuranosyl residues (34, 67).
Trejo et al. (46) isolated a nucleotide sugar formed in
cell-free enzyme preparations of P. charlesii, which was
capable of acting as a donor of galactofuranosyl residues in the
biosynthesis of a galactofuranosyl-containing polymer. Based on
chemical analysis of the reaction products obtained by acid and
alkaline hydrolosis as well as periodate oxidation, Trejo et
al. (46) predicted that the sugar nucleotide is
UDP-Galf. More recently, Nassau et al. (48)
cloned the glf gene of E. coli and showed that it
encodes UDP-galactopyranose mutase (EC 5.4.99.9). Nassau et
al. (48) concluded that the reaction product of the
UDP-galactopyranose mutase reaction is UDP-Galf based on
HPLC analysis of the sugar 1-phosphate obtained after phosphodiesterase
treatment of the reaction product. The modification of an HPAEC
procedure, to give a method that separates UDP-Galp from
UDP-Galf, allowed us for the first time to purify milligram quantities of UDP-Galf and to unequivocally prove by NMR the
structure to be uridine 5 -(trihydrogen diphosphate)
P - -D-galactofuranosyl ester. This will provide an
essential reagent for biochemical analyses of synthetic systems for
galactofuranosyl-containing glycoconjugates.
The data presented here establish that RfbDKPO1 catalyzes
the interconversion of UDP-Galp and UDP-Galf. The
LPS profiles of E. coli K-12 strains containing pWQ70 and
pWQ71 clearly demonstrated that Glf (48) of E. coli can
complement the rfbDKPO1 deletion in pWQ70. Glf
and RfbDKPO1 are therefore functionally equivalent. Although the K. pneumoniae RfbDKPO1 protein
shows 37.5% identity to Glf of E. coli, the two proteins do
exhibit remarkable differences. Glf has been reported to be relatively
unstable, resulting in complete loss of activity after storage of the
purified protein at 4 °C for >24 h (48). In contrast,
RfbDKPO1 can be stored at 4 °C for periods in excess of
1-2 weeks without significant loss of activity (data not shown).
Moreover, no cofactor requirement other than FAD has been reported for
Glf, while RfbDKPO1 has an absolute requirement for NADH or
NADPH. These differences are difficult to explain. One possibility is
that the binding constants for NADH (NADPH) are different in both
proteins. Alternatively, the differences may be a result of the
purification procedure used. Cibacron Blue 3GA used in the purification
procedure reported here is thought to bind to NAD binding sites.
Consequently, binding of the enzyme to this resin may displace the
essential cofactor. Analysis of the predicted sequence of both proteins
revealed a ADP-binding   -fold at its N terminus, which could be
involved in binding FAD or NAD. The motif in K. pneumoniae
differs at Gly-19 from the fingerprint. However, the known structure of
p-hydroxybenzoate hydroxylase, which has a glycine at the
same position (position 15 of the fingerprint), demonstrates that
peptides with a glycine at this position can form a functional
  unit (68). The presence of FAD in the purified Glf protein
has been reported (48). Although we have not analyzed this cofactor in
RfbDKPO1, the yellow color of the pure protein is
consistent with its containing FAD. Gel filtration of the
RfbDKPO1 protein on Superose 12 revealed a molecular weight
of 92,000 for the native protein. The possible dimerization of Glf has
not been investigated.
Little is known about the mechanism of the UDP-galactopyranose mutase
(NAD(P)H-requiring) reaction. Stevenson et al. (47) suggested that the reaction may proceed via a 2-keto intermediate. Since in our hands the UDP-galactopyranose mutase reaction shows an
absolute requirement for NADH or NADPH and was found to be inactive
with NAD or NADP, an alternative is that the first step of the reaction
may be a reduction step, although there is no net oxidation/reduction
in the interconversion of UDP-Galp and UDP-Galf.
The stability of the RfbDKPO1 protein and the possibility to synthesize and purify larger quantities of UDP-Galf will
facilitate a detailed analysis of the reaction mechanism and
determination of the protein structure.
FOOTNOTES
*
This work was supported by grants (to C. W.) from the
Canadian Bacterial Diseases Network, one of the federal Networks of Centers of Excellence. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) L31762[GenBank] (for rfbCDEFKPO1).
¶
To whom correspondence and reprint requests should be
addressed. Tel.: 519-837-4120 (ext. 3478); Fax: 519-837-1802; E-mail: cwhitfie{at}micro.uoguelph.ca.
1
The abbreviations used are: LPS,
lipopolysaccharide; UDP-Galp or UDP-galactopyranose, uridine
5 -(trihydrogen diphosphate) P - -D-galactopyranosyl
ester; UDP-Galf or UDP-galactofuranose, uridine
5 -(trihydrogen diphosphate) P - -D-galactofuranosyl
ester; Galf-1,2-P, -D-galactofuranose cyclic
1,2-(hydrogen phosphate); HPAEC, high performance anion exchange
chromatography; COSY, correlated spectroscopy; TOCSY, total correlation
spectroscopy; HMQC, heteronuclear multiple-quantum coherence; PAGE,
polyacrylamide gel electrophoresis; S-LPS, smooth LPS; HPLC, high
performance liquid chromatography.
Acknowledgments
We gratefully acknowledge the technical
assistance provided by Karen Sutherland. We thank K. Duncan and
colleagues for discussions and sharing data on glf prior to
its publication.
Note Added in Proof
While this manuscript was in press, a
report by others independently confirmed the nature and structure of
UDP-Galf as the product of the UDP-galactopyranose mutase
reaction (Lee, R., Monsey, D., Weston, A., Duncan, K., Rithner, C., and
McNeil, M. (1996) Anal. Biochem. 242, 1-7).
REFERENCES
-
Whitfield, C., Richards, J. C., Perry, M. B., Clarke, B. R., and MacLean, L. L.
(1991)
J. Bacteriol.
173,
1420-1431
[Abstract/Free Full Text]
-
Kelly, R. F., Perry, M. B., MacLean, L. L., and Whitfield, C.
(1995)
J. Endotox. Res.
2,
131-140
-
Kelly, R. F., Severn, W. B., Richards, J. C., Perry, M. B., McLean, L. L., Tomás, J. M., Merino, S., and Whitfield, C.
(1993)
Mol. Microbiol.
10,
615-625
[CrossRef][Medline]
[Order article via Infotrieve]
-
Whitfield, C., Perry, M. B., MacLean, L. L., and Yu, S. H.
(1992)
J. Bacteriol.
174,
4913-4919
[Abstract/Free Full Text]
-
Kol, O., Wieruszeski, J.-M., Strecker, G., Montreuil, J., Fournet, B., Zalisz, R., and Smets, P.
(1991)
Carbohydr. Res.
217,
117-125
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kol, O., Wieruszeski, J.-M., Strecker, G., Fournet, B., Zalisz, R., and Smets, P.
(1992)
Carbohydr. Res.
236,
339-344
[CrossRef][Medline]
[Order article via Infotrieve]
-
Oxley, D., and Wilkinson, S. G.
(1988)
Carbohydr. Res.
172,
287-291
[CrossRef][Medline]
[Order article via Infotrieve]
-
Oxley, D., and Wilkinson, S. G.
(1989)
Carbohydr. Res.
193,
241-248
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dmitriev, B. A., L'vov, V. L., and Kochetkov, N. K.
(1977)
Carbohydr. Res.
56,
207-209
[CrossRef][Medline]
[Order article via Infotrieve]
-
L'vov, V. L., Dashunin, V. M., Ramos, E. L., Shashkov, A. S., Dmitriev, B. A., and Kochetkov, N. K.
(1983)
Carbohydr. Res.
124,
141-149
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jann, B., Shashkov, A. S., Kochanowski, H., and Jann, K.
(1994)
Carbohydr. Res.
264,
305-311
[CrossRef][Medline]
[Order article via Infotrieve]
-
Perry, M. B., and Babiuk, L. A.
(1984)
Can. J. Biochem. Cell Biol.
62,
108-114
-
Altman, E., Brisson, J.-R., and Perry, M. B.
(1988)
Carbohydr. Res.
179,
245-258
[CrossRef][Medline]
[Order article via Infotrieve]
-
Perry, M. B.
(1990)
Biochem. Cell Biol.
68,
808-810
[Medline]
[Order article via Infotrieve]
-
Berst, M., Lüderitz, O., and Westphal, O.
(1971)
Eur. J. Biochem.
18,
361-368
[Medline]
[Order article via Infotrieve]
-
Abeygunawardana, C., Bush, C. A., and Cisar, J. O.
(1991)
Biochemistry
30,
8568-8577
[CrossRef][Medline]
[Order article via Infotrieve]
-
Abeygunawardana, C., Bush, C. A., and Cisar, J. O.
(1991)
Biochemistry
30,
6528-6540
[CrossRef][Medline]
[Order article via Infotrieve]
-
Abeygunawardana, C., Bush, C. A., and Cisar, J. O.
(1990)
Biochemistry
29,
234-248
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bax, A., Summers, M. F., Egan, W., Guirgis, N., Schneerson, R., Robbins, J. B., Ørskov, F., Ørskov, I., and Vann, W. F.
(1988)
Carbohydr. Res.
173,
53-64
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dutton, G. G. S., Parolis, H., and Parolis, L. A. S.
(1985)
Carbohydr. Res.
140,
263-275
[CrossRef][Medline]
[Order article via Infotrieve]
-
Besra, G. S., Khoo, K.-H., McNeil, M. R., Dell, A., Morris, H. R., and Brennan, P. J.
(1995)
Biochemistry
34,
4257-4266
[CrossRef][Medline]
[Order article via Infotrieve]
-
Daffe, M., McNeil, M., and Brennan, P. J.
(1993)
Carbohydr. Res.
249,
383-398
[CrossRef][Medline]
[Order article via Infotrieve]
-
Plackett, P., and Buttery, S. H.
(1964)
Biochem. J.
90,
201-205
[Medline]
[Order article via Infotrieve]
-
Christian, R., Schulz, G., Schuster-Kolbe, J., Allmaier, G., Schmid, E. R., Sleytr, U. B., and Messner, P.
(1993)
J. Bacteriol.
175,
1250-1256
[Abstract/Free Full Text]
-
Gerwig, G. J., de Waard, P., Kamerling, J. P., Vliegenthart, J. F. G., Morgenstern, E., Lamed, R., and Bayer, E. A.
(1989)
J. Biol. Chem.
264,
1027-1035
[Abstract/Free Full Text]
-
Gerwig, G. J., Kamerling, J. P., Vliegenthart, J. F. G., Morag, E., Lamed, R., and Bayer, E. A.
(1993)
J. Biol. Chem.
268,
26956-26960
[Abstract/Free Full Text]
-
Turco, S. J., Orlandi, P. A., Jr., Homans, S. W., Ferguson, M. A. J., Dwek, R. A., and Rademacher, T. W.
(1989)
J. Biol. Chem.
264,
6711-6715
[Abstract/Free Full Text]
-
McConville, M. J., Thomas-Oates, J. E., Ferguson, M. A. J., and Homans, S. W.
(1990)
J. Biol. Chem.
265,
19611-19623
[Abstract/Free Full Text]
-
Ilg, T., Etges, R., Overath, P., McConville, M. J., Thomas-Oates, J., Thomas, J., Homans, S. W., and Ferguson, M. A. J.
(1992)
J. Biol. Chem.
267,
6834-6840
[Abstract/Free Full Text]
-
Mendelzon, D. H., and Parodi, A. J.
(1986)
J. Biol. Chem.
261,
2129-2133
[Abstract/Free Full Text]
-
Previato, J. O., Gorin, P. A. J., Mazurek, M., Xavier, M. T., Fournet, B., Wieruszeski, J. M., and Mendonca-Previato, L.
(1990)
J. Biol. Chem.
265,
2518-2526
[Abstract/Free Full Text]
-
Unkefer, C. J., and Gander, J. E.
(1979)
J. Biol. Chem.
254,
12131-12135
[Free Full Text]
-
Parra, E., Jiménez-Barbero, J., Bernabe, M., Leal, J. A., Prieto, A., and Gómez-Miranda, B.
(1994)
Carbohydr. Res.
257,
239-248
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gorin, P. A. J., and Spencer, J. F. T.
(1959)
Can. J. Chem.
37,
499-502
[CrossRef]
-
Takayanagi, T., Kimura, A., Chiba, S., and Ajisaka, K.
(1994)
Carbohydr. Res.
256,
149-158
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nakajima, T., Yoshida, M., Nakamura, M., Hiura, N., and Matsuda, K.
(1984)
J. Biochem. (Tokyo)
96,
1013-1020
[Abstract/Free Full Text]
-
Barr, K., Laine, R. A., and Lester, R. L.
(1984)
Biochemistry
23,
5589-5596
[CrossRef][Medline]
[Order article via Infotrieve]
-
McNeil, M. R., and Brennan, P. J.
(1991)
Res. Microbiol.
142,
451-463
[Medline]
[Order article via Infotrieve]
-
Bronner, D., Clarke, B. R., and Whitfield, C.
(1994)
Mol. Microbiol.
14,
505-519
[CrossRef][Medline]
[Order article via Infotrieve]
-
Meier-Dieter, U., Barr, K., Starman, R., Hatch, L., and Rick, P. D.
(1992)
J. Biol. Chem.
267,
746-753
[Abstract/Free Full Text]
-
Clarke, B. A., Bronner, D., Keenleyside, W. J., Severn, W. B., Richards, J. C., and Whitfield, C.
(1995)
J. Bacteriol.
177,
5411-5418
[Abstract/Free Full Text]
-
Clarke, B. R., and Whitfield, C.
(1992)
J. Bacteriol.
174,
4614-4621
[Abstract/Free Full Text]
-
Weikert, M. J., and Adhya, S.
(1993)
Mol. Microbiol.
10,
245-251
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nikaido, H., and Sarvas, M.
(1971)
J. Bacteriol.
105,
1073-1082
[Abstract/Free Full Text]
-
Sarvas, M., and Nikaido, H.
(1971)
J. Bacteriol.
105,
1063-1072
[Abstract/Free Full Text]
-
Trejo, A. G., Chittenden, G. J. F., Buchanan, J. G., and Baddiley, J.
(1970)
Biochem. J.
117,
637-639
[Medline]
[Order article via Infotrieve]
-
Stevenson, G., Neal, B., Liu, D., Hobbs, M., Packer, N. H., Batley, M., Redmond, J. W., Lindquist, L., and Reeves, P.
(1994)
J. Bacteriol.
176,
4144-4156
[Abstract/Free Full Text]
-
Nassau, P. M., Martin, S. L., Brown, R. E., Weston, A., Monsey, D., McNeil, M. R., and Duncan, K.
(1996)
J. Bacteriol.
178,
1047-1052
[Abstract/Free Full Text]
-
Sambrook, J., Fritsch, E. F., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Thompson, J. D., Higgins, D. G., and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680
[Abstract/Free Full Text]
-
Deng, W. P., and Nickoloff, J. A.
(1992)
Anal. Biochem.
200,
81-88
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hitchcock, P. J., and Brown, T. M.
(1983)
J. Bacteriol.
154,
269-277
[Abstract/Free Full Text]
-
Lesse, A. J., Campagnari, A. A., Bittner, W. E., and Apicella, M. A.
(1990)
J. Immunol. Methods
126,
109-117
[CrossRef][Medline]
[Order article via Infotrieve]
-
Tsai, C.-M., and Frasch, C. E.
(1982)
Anal. Biochem.
119,
115-119
[CrossRef][Medline]
[Order article via Infotrieve]
-
Palmieri, M. J., Berry, G. T., Player, D. A., Rogers, S., and Segal, S.
(1991)
Anal. Biochem.
194,
388-393
[CrossRef][Medline]
[Order article via Infotrieve]
-
Baumann, H., Tzianabos, A. O., Brisson, J.-R., Kasper, D. L., and Jennings, H. J.
(1992)
Biochemistry
31,
4081-4089
[CrossRef][Medline]
[Order article via Infotrieve]
-
Uhrin, D., Brisson, J.-R., MacLean, L. L., Richards, J. C., and Perry, M. B.
(1994)
J. Biomol. NMR
4,
615-630
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wierenga, R. K., Terpstra, P., and Hol, W. G. J.
(1986)
J. Mol. Biol.
187,
101-107
[CrossRef][Medline]
[Order article via Infotrieve]
-
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kelly, R. F., and Whitfield, C.
(1996)
J. Bacteriol.
178,
5205-5214
[Abstract/Free Full Text]
-
Yao, Z., and Valvano, M. A.
(1994)
J. Bacteriol.
176,
4133-4143
[Abstract/Free Full Text]
-
Fujita, K.-i., Maeda, K., Tanaka, T., Taniguchi, M., and Oi, S.
(1993)
Biosci. Biotech. Biochem.
57,
1166-1171
-
Gorenstein, D. G.
(1984)
in
Phosphorous-31 NMR: Principles and Applications (Gorenstein, D. G., ed), pp. 7-53, Academic Press, Inc., Orlando, FL
-
Bock, K., Pedersen, C., and Pedersen, H.
(1984)
Adv. Carbohydr. Chem. Biochem.
42,
193-225
-
Lee, C.-H., and Sarma, R. H.
(1976)
Biochemistry
15,
697-704
[CrossRef][Medline]
[Order article via Infotrieve]
-
Davies, D. B., and Danyluk, S. S.
(1974)
Biochemistry
13,
4417-4434
[CrossRef][Medline]
[Order article via Infotrieve]
-
Haworth, W. N., Raistrick, H., and Stacey, M.
(1937)
Biochem. J.
31,
640-644
-
Wierenga, R. K., Drenth, J., and Schulz, G. E.
(1983)
J. Mol. Biol.
167,
725-739
[Medline]
[Order article via Infotrieve]
-
Neuhard, J., and Thomassen, E.
(1976)
J. Bacteriol.
126,
999-1001
[Abstract/Free Full Text]
-
Kovach, M. E., Phillips, R. W., Elzer, P. H., Roop, R. M., II, and Peterson, K. M.
(1994)
BioTechniques
16,
800-802
[Medline]
[Order article via Infotrieve]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. S. Schmalhorst, S. Krappmann, W. Vervecken, M. Rohde, M. Muller, G. H. Braus, R. Contreras, A. Braun, H. Bakker, and F. H. Routier
Contribution of Galactofuranose to the Virulence of the Opportunistic Pathogen Aspergillus fumigatus
Eukaryot. Cell,
August 1, 2008;
7(8):
1268 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kleczka, A.-C. Lamerz, G. van Zandbergen, A. Wenzel, R. Gerardy-Schahn, M. Wiese, and F. H. Routier
Targeted Gene Deletion of Leishmania major UDP-galactopyranose Mutase Leads to Attenuated Virulence
J. Biol. Chem.,
April 6, 2007;
282(14):
10498 - 10505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Konishi, T. Takeda, Y. Miyazaki, M. Ohnishi-Kameyama, T. Hayashi, M. A. O'Neill, and T. Ishii
A plant mutase that interconverts UDP-arabinofuranose and UDP-arabinopyranose
Glycobiology,
March 1, 2007;
17(3):
345 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Beverley, K. L. Owens, M. Showalter, C. L. Griffith, T. L. Doering, V. C. Jones, and M. R. McNeil
Eukaryotic UDP-Galactopyranose Mutase (GLF Gene) in Microbial and Metazoal Pathogens
Eukaryot. Cell,
June 1, 2005;
4(6):
1147 - 1154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. Mulrooney, K. K. H. Poon, D. J. McNally, J.-R. Brisson, and J. S. Lam
Biosynthesis of UDP-N-acetyl-L-fucosamine, a Precursor to the Biosynthesis of Lipopolysaccharide in Pseudomonas aeruginosa Serotype O11
J. Biol. Chem.,
May 20, 2005;
280(20):
19535 - 19542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Miller, C. Q. Wenzel, C. Daniels, S. Larocque, J.-R. Brisson, and J. S. Lam
Biochemical Characterization of WbpA, a UDP-N-acetyl-D-glucosamine 6-Dehydrogenase Involved in O-antigen Biosynthesis in Pseudomonas aeruginosa PAO1
J. Biol. Chem.,
September 3, 2004;
279(36):
37551 - 37558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. El Zoeiby, F. Sanschagrin, A. Darveau, J.-R. Brisson, and R. C. Levesque
Identification of novel inhibitors of Pseudomonas aeruginosa MurC enzyme derived from phage-displayed peptide libraries
J. Antimicrob. Chemother.,
March 1, 2003;
51(3):
531 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kneidinger, K. O'Riordan, J. Li, J.-R. Brisson, J. C. Lee, and J. S. Lam
Three Highly Conserved Proteins Catalyze the Conversion of UDP-N-acetyl-D-glucosamine to Precursors for the Biosynthesis of O Antigen in Pseudomonas aeruginosa O11 and Capsule in Staphylococcus aureus Type 5. IMPLICATIONS FOR THE UDP-N-ACETYL-L-FUCOSAMINE BIOSYNTHETIC PATHWAY
J. Biol. Chem.,
January 31, 2003;
278(6):
3615 - 3627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schaffer, T. Wugeditsch, P. Messner, and C. Whitfield
Functional Expression of Enterobacterial O-Polysaccharide Biosynthesis Enzymes in Bacillus subtilis
Appl. Envir. Microbiol.,
October 1, 2002;
68(10):
4722 - 4730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Hancock and M. S. Gilmore
The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall
PNAS,
February 5, 2002;
99(3):
1574 - 1579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Crick, S. Mahapatra, and P. J. Brennan
Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis
Glycobiology,
September 1, 2001;
11(9):
107R - 118R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pan, M. Jackson, Y. Ma, and M. McNeil
Cell Wall Core Galactofuran Synthesis Is Essential for Growth of Mycobacteria
J. Bacteriol.,
July 1, 2001;
183(13):
3991 - 3998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Guan, A. J. Clarke, and C. Whitfield
Functional Analysis of the Galactosyltransferases Required for Biosynthesis of D-Galactan I, a Component of the Lipopolysaccharide O1 Antigen of Klebsiella pneumoniae
J. Bacteriol.,
June 1, 2001;
183(11):
3318 - 3327.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Graninger, B. Nidetzky, D. E. Heinrichs, C. Whitfield, and P. Messner
Characterization of dTDP-4-dehydrorhamnose 3,5-Epimerase and dTDP-4-dehydrorhamnose Reductase, Required for dTDP-L-rhamnose Biosynthesis in Salmonella enterica Serovar Typhimurium LT2
J. Biol. Chem.,
August 27, 1999;
274(35):
25069 - 25077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chen and W. R. Bishai
Novel Selection for Isoniazid (INH) Resistance Genes Supports a Role for NAD+-Binding Proteins in Mycobacterial INH Resistance
Infect. Immun.,
November 1, 1998;
66(11):
5099 - 5106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mikusova, T. Yagi, R. Stern, M. R. McNeil, G. S. Besra, D. C. Crick, and P. J. Brennan
Biosynthesis of the Galactan Component of the Mycobacterial Cell Wall
J. Biol. Chem.,
October 20, 2000;
275(43):
33890 - 33897.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|